PUBBLICAZIONI

2021

Cancer immunity and immunotherapy beyond COVID-19.

Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Cancer Immunol Immunother.
2023 Jul;72(7):2541-2548. doi: 10.1007/s00262-023-03411-9. Epub 2023 Mar 30.

2020

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020

Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP.Cancer Immunol Immunother.
2022 Jul;71(7):1787-1794. doi: 10.1007/s00262-022-03145-0. Epub 2022 Jan 16.PMID: 35034143
No abstract available.

2019

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.

Bellone M, Bregni M, Bronte V, Ugel S, Ferrucci PF, Di Nicola M, Nisticò P, Zuccolotto G, Rosato A, Russo V, Sica A, Colombo MP.Cancer Immunol Immunother.
2022 Jul;71(7):1777-1786. doi: 10.1007/s00262-021-03104-1. Epub 2021 Nov 9.PMID: 34755203
No abstract available.

2018

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.

Bellone M, Brevi A, Bruzzì S, Consonni M, De Santis F, Di Lullo G, Majorini MT, Pastò A, Amadori A, Bregni M, Di Nicola M, Calabrò L, Ferrucci PF, Proietti E, Colombo MP, Russo V.Cancer Immunol Immunother.
2020 Jun;69(6):1141-1151. doi: 10.1007/s00262-020-02502-1. Epub 2020 Feb 6.PMID: 32025818
No abstract available.

2017

Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)

Russo V., Alberto A., Di Nicola M., Ferrucci PF, Proietti E, Maio M., Bellone M.
Cytokine Growth Factor Rev 2017 Aug;36:1-3. doi:10.1016/j.cytogfr.2017.06.004. Epub 2017 Jun 16. MID: 28634022

Abstract
The explosion in the immuno-oncology field, exemplified by the clinical implementation of immune checkpoint inhibitor blockade and other immunotherapeutic strategies was quickly recognized by the Italian biomedical community, thanks to the networking activities of the Italian Network for Tumor Biotherapy (NIBIT), which has been active since 2004 in the diffusion of new scientific and clinical findings in the fields of tumor immunology and immunotherapy. Numerous activities of NIBIT have also helped to overcome the hurdles associated with the clinical implementation of cancer immune-biotherapeutic strategies at the national and international levels. Looking forward, a concerted interaction of NIBIT with existing European networks focused on cancer bio-immunotherapy will further contribute to the development of improved therapies in the immuno-oncology field. This Introduction briefly summarizes the history and objectives of NIBIT, as well as the current activities of the Network.

2012

Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Parisi G, Cutaia O, Fonsatti E, Parmiani G.Cancer Immunol Immunother.
2013 Dec;62(12):1851-8. doi: 10.1007/s00262-013-1496-5. Epub 2013 Nov 5.PMID: 24190546
No abstract available

2011

Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Parisi G, Fonsatti E, Papamichail M, Parmiani G; NIBIT.Cancer Immunol Immunother.
2012 Sep;61(9):1599-608. doi: 10.1007/s00262-012-1304-7. Epub 2012 Jun 27.PMID: 22736255
No abstract available.

2010

Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Fonsatti E; NIBIT; Parmiani G.Cancer Immunol Immunother.
2011 Jun;60(6):901-7. doi: 10.1007/s00262-011-1006-6. Epub 2011 Mar 24.PMID: 21431916
No abstract available.

2009

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Fonsatti E, Parmiani G; NIBIT.Cancer Immunol Immunother.
2010 Dec;59(12):1895-901. doi: 10.1007/s00262-010-0832-2. Epub 2010 Mar 5.PMID: 20204388
No abstract available

2008

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Fonsatti E, Parmiani G; NIBIT.Cancer Immunol Immunother.
2010 Jun;59(6):963-9. doi: 10.1007/s00262-009-0696-5. Epub 2009 Mar 28.PMID: 19330329
No abstract available.

2007

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.

Maio M, Nicolay HJ, Ascierto P, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Anzalone L, Fonsatti E, Parmiani G.J Transl Med.
2008 Feb 12;6:8. doi: 10.1186/1479-5876-6-8.PMID: 18269750 Free PMC article.

Abstract
As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.